GlassScriptPhysician profile
Jaspreet Toor
NPI 1437562949
$4,090.87
in general payments reported to CMS, 2019-2025
15 companies · $879 in 2025
The $879 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $146 · 2021: $835 · 2022: $822 · 2023: $467 · 2024: $339 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954 · Travel and Lodging: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.00 |
| Travel and Lodging | $731.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,343.63 | 2021-2023 | Intracept |
| Spr Therapeutics, INC | $753.54 | 2022-2025 | Sprint Pns System |
| Abbott Laboratories | $558.91 | 2019-2024 | Proclaim |
| Medtronic USA, INC. | $381.93 | 2019-2020 | |
| Boston Scientific Corporation | $367.55 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Stryker Corporation | $145.04 | 2023 | Spinejack |
| Mml US, INC. | $130.65 | 2022 | |
| Vertos Medical, INC. | $81.82 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $67.01 | 2021-2023 | Xtampza, Belbuca |
| Nevro Corp. | $64.39 | 2019-2023 | Senza |
| Nalu Medical, INC. | $57.70 | 2023 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $40.90 | 2019-2021 | |
| Abbvie INC. | $40.68 | 2022 | |
| Saluda Medical Americas, INC. | $37.50 | 2025 | Evoke |
| Protega Pharmaceutials INC | $19.62 | 2024 | Roxybond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaspreet Toor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.